TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma (Q34043755)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma |
scientific article |
Statements
1 reference
TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma (English)
1 reference
Akiko Kuwahara
1 reference
Motohiro Yamamori
1 reference
Megumi Fujita
1 reference
Tatsuya Okuno
1 reference
Takao Tamura
1 reference
Kaori Kadoyama
1 reference
Noboru Okamura
1 reference
Tsutomu Nakamura
1 reference
Toshiyuki Sakaeda
1 reference
20 July 2010
1 reference
1 reference
29
1 reference
100
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference